Dedicated locality research platform
Enter your email address and you will receive
a link to reset your password
GE Healthcare, the renowned medical technology giant from the USA, is embarking on a significant expansion of its manufacturing operations in India through a strategic joint venture with Wipro, a prominent Indian conglomerate. This joint venture, operating under the name "GE Wipro," is a pivotal participant in the global medical technology and digital solutions landscape. It operates within the framework of the government's Production Linked Incentive (PLI) scheme, aimed at promoting the domestic production of medical devices in India.
The state-of-the-art facility will specialize in the production of an array of critical medical equipment, including CT machines, Cath Lab equipment, Ultrasound scanners, ECG machines, ventilators, and patient monitoring solutions. This endeavour is poised to strengthen the healthcare ecosystem in India, addressing both local and global health challenges. Notably, it aligns with the objectives of the "Atmanirbhar Bharat" scheme, fostering self-reliance in India by facilitating the domestic manufacture of medical devices while simultaneously creating employment opportunities.
Underpinning its commitment to the "Make In India" initiative, GE Healthcare intends to manufacture 80% of the medical devices locally. The company is the preeminent player in South Asia, focusing on healthcare challenges such as reducing maternal and infant mortality, early cancer detection, and combating heart diseases. Leveraging intelligent devices, GE Healthcare enables faster decision-making to enhance patient outcomes, while Wipro, a leading multinational corporation, adds its technological prowess to the partnership.
This collaboration between two industry titans has elevated the healthcare sector to new heights, promising to improve patient well-being not just in India but across the globe. Their shared vision is to create a healthier future and a world where healthcare knows no boundaries. This move is set to augment India's manufacturing capabilities, making healthcare solutions more affordable and accessible, while also streamlining delivery and response times, and reducing import duties for the Indian healthcare industry.
The manufacturing facility, established in Bangalore since 1991, has already produced an impressive 200,000 units of cutting-edge medical technology, enhancing India's standing in the global healthcare arena. India faces a dual challenge of healthcare disparities, with rural areas lacking adequate devices and facilities, while urban centres enjoy better healthcare access. With GE Wipro's commitment to producing a comprehensive range of healthcare devices, these disparities and challenges can be effectively addressed.
Notably, the PLI scheme has approved an investment of Rs. 1,206 crore, of which Rs. 714 crore has already been realized. Fourteen projects, focusing on the domestic production of 37 high-end medical devices, have been initiated, poised to revolutionize healthcare not only in India but also on the global stage.
Propscience is India’s dedicated property news portal. We cover the latest events, news, trends, deals, new launches and more.
All our services and tools are completely free of cost and available 24X7!
We use cookies to give you the best possible service while using our website, please click accept and carry on browsing if you're happy with this. For more information see our Privacy Policy.
Okay, Got it!This disclaimer ("Disclaimer") is applicable to the entire Site. Upon entering the Site it is recommended that you immediately read the Terms and Conditions and Privacy Policy listed therein. Your continued usage of this Site will indicate your unconditional acceptance of the said Terms and Conditions and Privacy Policy. You hereby agree that Propscience reserves the right to modify at any time, the Terms and Conditions and Privacy Policy governing this Site without prior notification. Your usage of the Site implies that you will be bound by any such modification. You agree and acknowledge that it is your responsibility to periodically visit the Site and stay updated with the Terms and Conditions and Privacy Policy of the Website.
The information contained in this Site has been provided by Propscience for information purposes only. This information does not constitute legal, professional or commercial advice. Communication, content and material within the Site may include photographs and conceptual representations of projects under development. All computer-generated images shown on the Site are only indicative of actual designs and are sourced from third party sites.
The information on this Site may contain certain technical inaccuracies and typographical errors. Any errors or omissions brought to the attention of Propscience will be corrected as soon as possible. The content of this Site is being constantly modified to meet the terms, stipulations and recommendations of the Real Estate Regulation Act, 2016 ("RERA") and rules made thereunder and may vary from the content available as of date. All content may be updated from time to time and may at times be out of date. Propscience accepts no responsibility for keeping the information in this website up to date or any liability whatsoever for any failure to do so.
While every care has been taken to ensure that the content is useful, reliable and accurate, all content and information on the Site is provided on an "as is" and "as available" basis. Propscience does not accept any responsibility or liability with regard to the content, accuracy, legality and reliability of the information provided herein, or, for any loss or damage caused arising directly or indirectly in connection with reliance on the use of such information. No information given under this Site creates a warranty or expands the scope of any warranty that cannot be disclaimed under applicable law.
This Site provides links to other websites owned by third parties. Any reference or mention to third party websites, projects or services is for purely informational purposes only. This information does not constitute either an endorsement or a recommendation. Propscience accepts no responsibility for the content, reliability and information provided on these third-party websites. Propscience will not be held liable for any personal information of data collected by these third parties or for any virus or destructive properties that may be present on these third-party sites.
Your use of the Site is solely at your own risk. You agree and acknowledge that you are solely responsible for any action you take based upon this content and that Propscience is not liable for the same. All details regarding a project/property provided on this Site are updated on the basis of information available from the respective developers/owners/promoters. All such information will not be construed as an advertisement. To find out more about a project / development, please register/contact us to visit the site you are interested in. All decisions taken by you in this regard will be taken independently and Propscience will not be liable for any such loss in connection with the same. This Site is for guidance only. Your use of this Site - including any suggestions set out in the Site and or any use of the resources available on this Site, do not create any professional - client relationship between you and Propscience. Propscience cannot accept you as a client until certain formalities and requirements are met.
We use cookies to give you the best possible service while using our website, please accept it and continue browsing if you're happy with this. For more information see our Privacy Policy